The major goal of the Neuropathology Core of the Rush ADCC is to facilitate research on normal aging, mild cognitive impairment, Alzheimer's disease and other dementias by collecting and then providing a diverse range of investigators a resource of optimally preserved, processed and stored biospecimens, and state-of the-art neuropathoiogic data and diagnoses, from clinically well-characterized older subjects. Over the past years, the Core has supported a diverse range of different studies including clinical-pathologic studies, studies of normal aging and mild cognitive impairment and studies linking risk factors to the neuropathology and neurobiology underlying normal aging, MCI, clinical AD and other dementias. In addition the core has distributed biospecimens to externally-funded investigators at Rush, at other NIA funded Alzheimer's disease centers, and other researchers across the country, and has facilitated the publication of numerous manuscripts in peer-reviewed journals. The Core will continue to facilitate these studies and publications by continuing to practice optimal autopsy and collection procedures to obtain optimal ante-mortem and postmortem specimens and continue to use the uniform, standard and flexible techniques for preservation, processing and storage that allow for diverse research studies. The core will implement and maintain a DNA bank for all living and deceased participants. The Core will continue to use state-of-the-art diagnostic assessments on brain tissue to diagnose Alzheimer's disease, cerebral infarcts, and Lewy body disease, and will expand assessments for novel markers of pathology including TDP-43 and FUS. Using modern data management systems the Neuropathology Core will index and store data and diagnoses making these readily available for external research. The Neuropathology Core will continue to distribute high quality specimens and neuropathoiogic data and diagnoses for externally funded investigators to facilitate and expand the scope of research on normal aging, MCI, Alzheimer's disease and other dementias.

Public Health Relevance

The Neuropathology Core will continue to facilitate new and support on-going studies of normal aging, MCI, AD and dementia by providing optimal biospecimens and collecting state-of-the-art neuropathoiogic data and diagnoses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010161-23
Application #
8494479
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
23
Fiscal Year
2013
Total Cost
$383,206
Indirect Cost
$132,745
Name
Rush University Medical Center
Department
Type
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Bernier, Patrick J; Gourdeau, Christian; Carmichael, Pierre-Hugues et al. (2017) Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults. CMAJ 189:E1472-E1480
Brenowitz, Willa D; Keene, C Dirk; Hawes, Stephen E et al. (2017) Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples. Neurobiol Aging 53:83-92
Sposato, Luciano A; Ruíz Vargas, Estefanía; Riccio, Patricia M et al. (2017) Milder Alzheimer's disease pathology in heart failure and atrial fibrillation. Alzheimers Dement 13:770-777
Buchman, Noa M; Leurgans, Sue E; Shah, Raj J et al. (2017) Urinary Incontinence, Incident Parkinsonism, and Parkinson's Disease Pathology in Older Adults. J Gerontol A Biol Sci Med Sci 72:1295-1301
Klaver, Andrea C; Coffey, Mary P; Bennett, David A et al. (2017) Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory study. Transl Neurodegener 6:32
Moga, Daniela C; Abner, Erin L; Wu, Qishan et al. (2017) Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimers Dement (N Y) 3:139-148
Ahmad, Faraz; Singh, Kunal; Das, Debajyoti et al. (2017) Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease. Antioxid Redox Signal 27:1269-1280
Yu, Lei; Dawe, Robert J; Buchman, Aron S et al. (2017) Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res 322:233-240
Burke, Shanna L; O'Driscoll, Janice; Alcide, Amary et al. (2017) Moderating risk of Alzheimer's disease through the use of anxiolytic agents. Int J Geriatr Psychiatry 32:1312-1321
Sennik, Simrin; Schweizer, Tom A; Fischer, Corinne E et al. (2017) Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data. J Alzheimers Dis 55:1519-1528

Showing the most recent 10 out of 689 publications